All treatments
Treatment
AVAMYS 27.5 micrograms/spray clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A prospective, randomized, double-blind placebo-controlled multicentre trial with mannan-conjugated birch pollen allergoids administered subcutaneously to adolescents and adults with birch pollen-induced allergic rhinitis or rhinoconjunctivitis.
This study is looking into a new treatment for birch pollen allergy. It compares a new vaccine-like medicine given by injection to a dummy treatment. The aim is to see if the new medicine can help reduce symptoms like sneezing and itchy eyes during pollen season.
For: birch pollen-induced allergic rhinitis birch pollen-induced allergic rhinoconjunctivitisGermany - AuthorisedTherapeutic confirmatory (Phase III)
A multicenter, double-blind, placebo-controlled, clinical trial to evaluate the efficacy and safety of two concentrations of a mixture of depigmented polymerized allergenic extracts of D. pteronyssinus and D. farinae, in patients suffering from allergic rhinoconjunctivitis with or without controlled asthma
This study looks at new treatments for allergies caused by dust mites, which can make your nose and eyes itchy and watery, and sometimes affect your breathing. We want to see if these treatments are safe and effective in reducing your symptoms.
For: Allergic rhinoconjunctivitis to Dermatophagoides pteronyssinus and Dermatophagoides farinaeSpain